Introduction
============

Studies in the ICU showed that a single amikacin dose of ≥25 mg/kg should be used in conditions of increased distribution volume (Vd) such as severe sepsis/shock \[[@B1]\]. However, no data are available for emergency department (ED) patients in the early phase of sepsis/septic shock. The purpose of this study was to determine whether a single amikacin dose of 25 versus 15 mg/kg results in PK/PD target attainment for ED patients.

Methods
=======

ED patients with severe sepsis/shock were randomly treated with a single amikacin dose of 25 versus 15 mg/kg. Blood samples were collected at +1 (peak), +6 hours and +24 hours (trough) after the start of infusion. Primary outcome was PK/PD target attainment defined as a peak/MIC \>8, corresponding with both actual MIC values documented from isolated pathogens, as well as EUCAST susceptibility breakpoints for Enterobacteriaceae and *P. aeruginosa*; that is, 8 mg/l. Noncompartmental analysis was used to calculate PK parameters.

Results
=======

During a study duration of 20 months, 50 patients were enrolled in each dosing regimen resulting in 100 peak concentrations, 92 and 88 +6 hours and +24 hours concentrations respectively. Target attainment using local MIC values (median 2 mg/l, documented in 56 isolated Gram-negative pathogens) was achieved in 95% in both groups (*P*= 0.98). Using EUCAST susceptibility breakpoints, the target was attained in 76% versus 40% in the 25 versus 15 mg/kg group, respectively (*P*\< 0.0001). Single-dose PK parameters are displayed in Table [1](#T1){ref-type="table"} and compared with the ones reported in the ICU \[[@B1]\].

  PK parameter        15 mg/kg ED        25 mg/kg ED        25 mg/kg ICU
  ------------------- ------------------ ------------------ -----------------
  Peak (mg/l)         58(47 to 70)^a^    91(72 to 105)^a^   73(62 to 90)
  Trough (mg/l)       6(3 to 12)         5(3 to 15)         7(2 to 15)
  Vd (l/kg)           0.3(0.3 to 0.5)    0.4(0.2 to 0.6)    0.4(0.3 to 0.5)
  Cl (ml/minute/kg)   1.6(1 to 2.3)^a^   2.2(1.4 to 3)^a^   1.9(1.3 to 3.5)

Cl, clearance. ^a^Mann-Whitney *U*\<0.05 15 versus 25 mg/kg ED patients.

Conclusion
==========

The EUCAST-based PK/PD target was only attained in 76% of patients treated with 25 mg/kg. However, in contrast to ICU patients, the majority of ED patients are treated for community-acquired infections, so MIC values are significantly lower than the EUCAST susceptibility breakpoints, warranting PK/PD target attainment in both 25 and 15 mg/kg dosing regimens when local epidemiology is taken into account.
